https://www.taxtmi.com/caselaws?id=361633 Pharmaceutical manufacturer sought advance ruling on GST rates for specific drug products. HC determined that specific entries in tax schedule override general entries, confirming applicant's eligibility for 5% tax rate for listed pharmaceutical products. The ruling validated the manufacturer's claim for lower GST rate based on precise classification of pharmaceutical items in tax notification. en-us Wed, 28 Mar 2018 00:00:00 +0530 Mon, 09 Jun 2025 17:26:00 +0530 TaxTMI RSS Generator https://www.taxtmi.com/caselaws?id=361633 Pharmaceutical manufacturer sought advance ruling on GST rates for specific drug products. HC determined that specific entries in tax schedule override general entries, confirming applicant's eligibility for 5% tax rate for listed pharmaceutical products. The ruling validated the manufacturer's claim for lower GST rate based on precise classification of pharmaceutical items in tax notification. Case-Laws GST Wed, 28 Mar 2018 00:00:00 +0530 https://www.taxtmi.com/caselaws?id=361633